Erste Asset Management Gmb H Madrigal Pharmaceuticals, Inc. Transaction History
Erste Asset Management Gmb H
- $11.9 Trillion
- Q2 2025
A detailed history of Erste Asset Management Gmb H transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 201,100 shares of MDGL stock, worth $72.2 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
201,100
Previous 164,400
22.32%
Holding current value
$72.2 Million
Previous $54.4 Billion
11.86%
% of portfolio
0.51%
Previous 0.7%
Shares
9 transactions
Others Institutions Holding MDGL
# of Institutions
353Shares Held
23.3MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$787 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$750 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$716 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$709 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$674 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...